GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2022 Earnings Call Transcript

Page 5 of 12

Operator: Thank you one moment for our next question. And that will come from the line of Eric Sheridan with Goldman Sachs. Your line is open.

Eric Sheridan: Thanks so much for taking the question. I want to come back to the comment you made earlier on in the call around how you might be a beneficiary as we go into a more volatile, maybe downward macro environment and people look to save money. Can you just help us better understand how you possibly try to capitalize on that type of environment? You know, do you run greater marketing campaigns around that? Do you try to be in front of your consumers to make them more aware of the savings that are available in app? Sort of how €“ how should we think about you sort of being exposed to that theme and then to some degree benefiting from it, if there is a shift downward in terms of savings behavior coupled with consumption in the vertical.

And then the second one would be, if we think about industry marketing solutions and how you continue to build that business for the long term, can you give us a little bit of color of how industry conversations continue to evolve with partners who are looking to deploy advertising and marketing dollars to drive awareness of their products on the platform, away from just a quarter-to-quarter dynamic, but maybe thinking more broadly about budget dynamics on a multiyear view in 2023 and beyond. Thanks so much.

Trevor Bezdek: Thank you. I appreciate the question. You know the macro environment I think relative to consumers looks like it’ll be a bit harder for consumers with inflation and other challenges. This is definitely an environment though that we believe is where we can shine, where GoodRx can help people. Fortunately, medication is one of the very last things people are going to substitute away from. You know we can help consumers save on prescriptions so they can afford their rent, so they can afford their other costs, you know because these are critical things they need to purchase for their health and their family’s health. So we do think it is helpful to the business, albeit you know, we want to be there to help people.

The other part of that is the moving on from this period of COVID. You know COVID was a, certainly challenging for our business where it decreased new prescriptions and others, where we’re definitely back to a much more normal environment. But the other aspect of that though is certain programs that were expanded in COVID that are now being curtailed. For example, Medicaid you know is being rolled back in certain states, and so we would expect people to come off Medicaid roles, and that is also a tailwind for our business as we can help those people as they move out of Medicaid and are needing to access services. How do that is, you know we’re very fortunate we have this amazing brand. We have access to consumers, we have access to healthcare providers, our largest source of people knowing about us remains word-of-mouth.

Page 5 of 12